Skip to main content
. Author manuscript; available in PMC: 2015 Jan 21.
Published in final edited form as: J Appl Econ (Chichester Engl). 2014 June/July;29(4):671–691. doi: 10.1002/jae.2343

Table II.

Mean treatment effects based on estimated PeT effects (surgery versus active surveillance)

Effect 7-year costs, 2009 $
Mean (95% CIa)
7-year surv. pr., %pt
Mean (95% CIa)
Average treatment effect (ATE) −30,056 (−115,807, 19,355) 7.4 (−17.7, 40.2)
Effect on the treated (TT) −28,191 (−115,877, 20,451) 7.4 (−17.1, 43.2)
Effect on the UNTREATED (TUT) −35,255 (−109,419, 16,543) 7.4 (−19.3, 30.8)
TT – TUT 7064 (−8,969, 15,340) 0.01 (−5.8, 13.3)
With perfect selection on survival PeTs
Average treatment effect −30,641 (−119,640, 22,116) 12.6 (2.5, 37.0)
Effect on the treated −28,332 (−119,927, 22,859) 12.7 (1.5, 40.5)
Effect on the untreated −28,332 (−117,645, 17,882) 12.4 (5.1, 26.7)
Gains with perfect selection
ATE(Sel) – ATE −585 (−14,394, 4,885) 5.2 (−3.4, 23.3)
TT(Sel) – TT −141 (−14,035, 5,475) 5.3 (−3.0, 21.9)

Note: Bold face indicates exclusion of zero from 95% CI.

a

95% CI based on bias-corrected estimates from 1000 bootstrap replicates.